Clinical Trial Update: Platin-based Chemotherapeutics to Enhance Dendritic Cell Vaccine Efficacy in Melanoma Patients [Phase 2]

View source ↗

Summary

Phase 2 trial investigating platinum-based chemotherapy to improve dendritic cell vaccine efficacy in melanoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Radboud University Medical Center | Conditions: Melanoma | Phase 2 | Status: COMPLETED